Upgrade to SI Premium - Free Trial

Oncolytics Biotech (ONCY)

0.84 -0.03 (3.45%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/10/26 *Est.)

Latest Headlines

Form 4 ONCOLYTICS BIOTECH INC For: Jun 01 Filed by: Pisano Wayne June 3, 2026 4:32 PM - SEC Filing Form 3 ONCOLYTICS BIOTECH INC For: Jun 01 Filed by: McAdory John Bearden June 3, 2026 4:32 PM - SEC Filing Form 4 ONCOLYTICS BIOTECH INC For: Jun 01 Filed by: RIGBY JONATHAN June 3, 2026 4:32 PM - SEC Filing Form 4 ONCOLYTICS BIOTECH INC For: Jun 01 Filed by: Look Kirk June 3, 2026 4:32 PM - SEC Filing Form 4 ONCOLYTICS BIOTECH INC For: Jun 01 Filed by: Holtham Angela June 3, 2026 4:32 PM - SEC Filing Form 4 ONCOLYTICS BIOTECH INC For: Jun 01 Filed by: Parsons James T. June 3, 2026 4:32 PM - SEC Filing Form 4 ONCOLYTICS BIOTECH INC For: Jun 01 Filed by: Kelly Jared June 3, 2026 4:31 PM - SEC Filing Form 4 ONCOLYTICS BIOTECH INC For: Jun 01 Filed by: Aromando Andrew June 3, 2026 4:31 PM - SEC Filing Form 3 ONCOLYTICS BIOTECH INC For: Jun 01 Filed by: Glover Stephen C. June 3, 2026 4:31 PM - SEC Filing Form 4 ONCOLYTICS BIOTECH INC For: Jun 01 Filed by: Andrews Patricia S June 3, 2026 4:31 PM - SEC Filing Form 4 ONCOLYTICS BIOTECH INC For: Jun 01 Filed by: Seizinger Bernd R. June 3, 2026 4:31 PM - SEC Filing Form 4 ONCOLYTICS BIOTECH INC For: Jun 01 Filed by: Hagerman Allison June 3, 2026 4:31 PM - SEC Filing Form 4 ONCOLYTICS BIOTECH INC For: Jun 01 Filed by: Glover Stephen C. June 3, 2026 4:30 PM - SEC Filing Form 4 ONCOLYTICS BIOTECH INC For: Jun 01 Filed by: McAdory John Bearden June 3, 2026 4:30 PM - SEC Filing Form 4 ONCOLYTICS BIOTECH INC For: Jun 01 Filed by: Brown Deborah Margaret June 3, 2026 4:30 PM - SEC Filing Form 4 ONCOLYTICS BIOTECH INC For: Jun 01 Filed by: Heineman Thomas Charles June 3, 2026 4:30 PM - SEC Filing Form 8-K ONCOLYTICS BIOTECH INC For: Jun 02 June 2, 2026 9:03 AM - SEC Filing Oncolytics Biotech adds Steve Glover to board, promotes John McAdory to COO June 2, 2026 9:00 AM - StreetInsider Oncolytics Biotech® Announces Appointment of Steve Glover to Board of Directors and Promotion of John McAdory to Chief Operating Officer June 2, 2026 9:00 AM - Globe NewsWire Form 8-K ONCOLYTICS BIOTECH INC For: Jun 01 June 1, 2026 9:06 AM - SEC Filing Oncolytics reports positive preclinical data for pelareorep-RAS combo June 1, 2026 9:03 AM - StreetInsider Oncolytics Biotech® Announces Positive Initial Preclinical Findings Supporting Further Evaluation of Pelareorep in Combination with RAS-Targeted Approaches June 1, 2026 9:00 AM - Globe NewsWire H.C. Wainwright Reiterates Buy Rating on Oncolytics Biotech (ONCY) May 26, 2026 6:59 AM - StreetInsider Form 8-K ONCOLYTICS BIOTECH INC For: May 22 May 22, 2026 9:03 AM - SEC Filing Oncolytics Biotech® to Present Data at ASCO 2026 Reinforcing Pelareorep’s Potential Across Gastrointestinal Tumors May 22, 2026 9:00 AM - Globe NewsWire Form 10-Q ONCOLYTICS BIOTECH INC For: Mar 31 May 14, 2026 4:30 PM - SEC Filing "Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies May 14, 2026 11:12 AM - StreetInsider "Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies May 14, 2026 10:55 AM - Globe NewsWire Form 8-K ONCOLYTICS BIOTECH INC For: May 04 May 4, 2026 9:04 AM - SEC Filing Oncolytics Biotech® Reports Durable Responses in Second-Line RAS-Mutant MSS Colorectal Cancer May 4, 2026 9:00 AM - Globe NewsWire Form 8-K ONCOLYTICS BIOTECH INC For: Apr 27 April 27, 2026 8:17 AM - SEC Filing Oncolytics receives FDA alignment on pivotal anal cancer study design April 27, 2026 8:10 AM - StreetInsider Oncolytics Aligns with FDA on Planned Pivotal Anal Cancer Study April 27, 2026 8:10 AM - Globe NewsWire H.C. Wainwright Reiterates Buy Rating on Oncolytics Biotech (ONCY) April 10, 2026 6:49 AM - StreetInsider Form F-10POS ONCOLYTICS BIOTECH INC April 8, 2026 5:05 PM - SEC Filing Form F-10POS ONCOLYTICS BIOTECH INC April 8, 2026 5:05 PM - SEC Filing Form F-10POS ONCOLYTICS BIOTECH INC April 8, 2026 5:05 PM - SEC Filing Form F-10POS ONCOLYTICS BIOTECH INC April 8, 2026 5:05 PM - SEC Filing Form F-10POS ONCOLYTICS BIOTECH INC April 8, 2026 5:05 PM - SEC Filing Form F-10POS ONCOLYTICS BIOTECH INC April 8, 2026 5:05 PM - SEC Filing Form F-10POS ONCOLYTICS BIOTECH INC April 8, 2026 5:05 PM - SEC Filing Form F-10POS ONCOLYTICS BIOTECH INC April 8, 2026 5:05 PM - SEC Filing Form F-10POS ONCOLYTICS BIOTECH INC April 8, 2026 5:05 PM - SEC Filing Form F-10POS ONCOLYTICS BIOTECH INC April 8, 2026 5:05 PM - SEC Filing Form AW ONCOLYTICS BIOTECH INC April 8, 2026 5:04 PM - SEC Filing Form AW ONCOLYTICS BIOTECH INC April 8, 2026 5:04 PM - SEC Filing Form AW ONCOLYTICS BIOTECH INC April 8, 2026 5:04 PM - SEC Filing Form AW ONCOLYTICS BIOTECH INC April 8, 2026 5:04 PM - SEC Filing Form AW ONCOLYTICS BIOTECH INC April 8, 2026 5:04 PM - SEC Filing Form AW ONCOLYTICS BIOTECH INC April 8, 2026 5:04 PM - SEC Filing Form AW ONCOLYTICS BIOTECH INC April 8, 2026 5:04 PM - SEC Filing Form AW ONCOLYTICS BIOTECH INC April 8, 2026 5:04 PM - SEC Filing Form AW ONCOLYTICS BIOTECH INC April 8, 2026 5:04 PM - SEC Filing Form AW ONCOLYTICS BIOTECH INC April 8, 2026 5:04 PM - SEC Filing Oncolytics Biotech (ONCY) PT Lowered to $5 at Lake Street April 7, 2026 8:43 AM - StreetInsider Form F-10POS ONCOLYTICS BIOTECH INC April 6, 2026 5:20 PM - SEC Filing Form F-10POS ONCOLYTICS BIOTECH INC April 6, 2026 5:20 PM - SEC Filing Form F-10POS ONCOLYTICS BIOTECH INC April 6, 2026 5:20 PM - SEC Filing Form F-10POS ONCOLYTICS BIOTECH INC April 6, 2026 5:20 PM - SEC Filing Form F-10POS ONCOLYTICS BIOTECH INC April 6, 2026 5:20 PM - SEC Filing Form F-10POS ONCOLYTICS BIOTECH INC April 6, 2026 5:20 PM - SEC Filing Form F-10POS ONCOLYTICS BIOTECH INC April 6, 2026 5:20 PM - SEC Filing Form F-10POS ONCOLYTICS BIOTECH INC April 6, 2026 5:20 PM - SEC Filing Form F-10POS ONCOLYTICS BIOTECH INC April 6, 2026 5:20 PM - SEC Filing Form F-10POS ONCOLYTICS BIOTECH INC April 6, 2026 5:20 PM - SEC Filing Jones Trading Assumes Oncolytics Biotech (ONCY) at Hold April 6, 2026 4:17 PM - StreetInsider Form 8-K ONCOLYTICS BIOTECH INC For: Apr 06 April 6, 2026 4:13 PM - SEC Filing Form 424B5 ONCOLYTICS BIOTECH INC April 6, 2026 4:12 PM - SEC Filing Form 8-K ONCOLYTICS BIOTECH INC For: Apr 06 April 6, 2026 9:25 AM - SEC Filing Oncolytics Biotech schedules FDA meeting on anal cancer drug pathway April 6, 2026 9:00 AM - StreetInsider Oncolytics Biotech® Announces Type C FDA Meeting to Discuss Single-arm Registrational Pathway for Pelareorep in Anal Cancer April 6, 2026 9:00 AM - Globe NewsWire Form EFFECT ONCOLYTICS BIOTECH INC April 6, 2026 6:01 AM - SEC Filing Form EFFECT ONCOLYTICS BIOTECH INC April 2, 2026 6:07 AM - SEC Filing Form 8-K ONCOLYTICS BIOTECH INC For: Mar 31 April 1, 2026 9:07 AM - SEC Filing Oncolytics Biotech completes incorporation change from Canada to Nevada April 1, 2026 9:02 AM - StreetInsider Oncolytics Biotech® Completes Domicile Change to the United States April 1, 2026 9:01 AM - Globe NewsWire Oncolytics Biotech (ONCY) files $250M mixed shelf April 1, 2026 6:08 AM - StreetInsider Form F-10POS ONCOLYTICS BIOTECH INC April 1, 2026 6:06 AM - SEC Filing Form F-10POS ONCOLYTICS BIOTECH INC April 1, 2026 6:06 AM - SEC Filing Form F-10POS ONCOLYTICS BIOTECH INC April 1, 2026 6:06 AM - SEC Filing Form F-10POS ONCOLYTICS BIOTECH INC April 1, 2026 6:06 AM - SEC Filing Form F-10POS ONCOLYTICS BIOTECH INC April 1, 2026 6:06 AM - SEC Filing Form F-10POS ONCOLYTICS BIOTECH INC April 1, 2026 6:06 AM - SEC Filing Form F-10POS ONCOLYTICS BIOTECH INC April 1, 2026 6:06 AM - SEC Filing Form F-10POS ONCOLYTICS BIOTECH INC April 1, 2026 6:06 AM - SEC Filing Form F-10POS ONCOLYTICS BIOTECH INC April 1, 2026 6:06 AM - SEC Filing Form S-8 ONCOLYTICS BIOTECH INC April 1, 2026 6:06 AM - SEC Filing Form S-3 ONCOLYTICS BIOTECH INC April 1, 2026 6:06 AM - SEC Filing Form F-10POS ONCOLYTICS BIOTECH INC April 1, 2026 6:06 AM - SEC Filing Form POS AM ONCOLYTICS BIOTECH INC April 1, 2026 6:06 AM - SEC Filing Form S-8 POS ONCOLYTICS BIOTECH INC April 1, 2026 6:06 AM - SEC Filing Form S-8 POS ONCOLYTICS BIOTECH INC April 1, 2026 6:06 AM - SEC Filing Form 10-K ONCOLYTICS BIOTECH INC For: Dec 31 March 30, 2026 5:32 PM - SEC Filing Form 8-K ONCOLYTICS BIOTECH INC For: Mar 17 March 20, 2026 4:44 PM - SEC Filing The Patent Cliff is Coming, Driving Smart Money Towards Precision Oncology March 19, 2026 11:00 AM - StreetInsider Form 8-K ONCOLYTICS BIOTECH INC For: Mar 19 March 19, 2026 9:06 AM - SEC Filing Oncolytics Biotech® to Present New Mechanistic and Translational Data Supporting Pelareorep as an Immune-Priming Backbone at AACR 2026 March 19, 2026 9:01 AM - Globe NewsWire Form 4 ONCOLYTICS BIOTECH INC For: Mar 11 Filed by: Parsons James T. March 13, 2026 8:00 AM - SEC Filing Form 4 ONCOLYTICS BIOTECH INC For: Mar 12 Filed by: Kelly Jared March 13, 2026 8:00 AM - SEC Filing Full Article List